Insider Buying: Smith & Nephew plc (LON:SN) Insider Acquires 5,344 Shares of Stock

Smith & Nephew plc (LON:SN) insider Rupert Soames purchased 5,344 shares of the company’s stock in a transaction that occurred on Monday, November 11th. The stock was bought at an average price of GBX 936 ($12.04) per share, for a total transaction of £50,019.84 ($64,367.31).

Smith & Nephew Trading Up 1.0 %

SN stock opened at GBX 961 ($12.37) on Friday. The firm’s 50-day moving average is GBX 1,101.16 and its 200 day moving average is GBX 1,077.03. The firm has a market cap of £8.38 billion, a P/E ratio of 3,523.70, a price-to-earnings-growth ratio of 0.46 and a beta of 0.62. The company has a debt-to-equity ratio of 70.22, a quick ratio of 0.84 and a current ratio of 2.51.

Wall Street Analysts Forecast Growth

Separately, Berenberg Bank reiterated a “buy” rating and set a £145 ($186.59) price target on shares of Smith & Nephew in a research note on Monday, August 5th. One analyst has rated the stock with a hold rating and four have given a buy rating to the company. According to data from MarketBeat, Smith & Nephew currently has an average rating of “Moderate Buy” and an average price target of GBX 3,956.20 ($50.91).

About Smith & Nephew

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.